Skip to content

Exercise and Glycemic Control in Type 2 Diabetes

Defining the Optimal Exercise Program to Improve Glycemic Control in Various Stages of Type 2 Diabetes.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00945165
Enrollment
124
Registered
2009-07-24
Start date
2009-07-31
Completion date
2012-06-30
Last updated
2012-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Hyperglycemia

Keywords

Continuous Glucose Monitoring System, Exercise

Brief summary

Hyperglycemia is an independent risk factor for the development of diabetic complications in type 2 diabetes. Exercise improves glycemic control, however, the role of exercise characteristics (e.g. intensity, type of exercise, timing, frequency) remains to be elucidated. This study aims to assess the effect of several exercise characteristics on hyperglycemia in various subgroups of type 2 diabetes patiënts.

Interventions

BEHAVIORALExercise intervention

various exercise characteristics

BEHAVIORALNo exercise

No exercise control period

Sponsors

ZonMw: The Netherlands Organisation for Health Research and Development
CollaboratorOTHER
Maastricht University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
40 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

Impaired glucose tolerant subjects Inclusion Criteria: * BMI 25 - 35 kg/m2 * Impaired Glucose Tolerant (according to ADA guidelines)

Exclusion criteria

* Cardiac disease (cardiac event in the last 5 years) * Type 2 diabetes * Use of orale blood glucose lowering medication or exogenous insulin * HbA1c \>10% Insulin treated type 2 diabetes patients Inclusion Criteria: * BMI 25 - 35 kg/m2 * Insulin therapy * diagnosed with type 2 diabetes \>2 yr

Design outcomes

Primary

MeasureTime frame
Hyperglycemia24h

Secondary

MeasureTime frame
Mean Blood Glucose24h

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026